Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) shares rose 7.1% during mid-day trading on Tuesday . The company traded as high as C$0.30 and last traded at C$0.30. Approximately 10,500 shares were traded during trading, a decline of 82% from the average daily volume of 59,890 shares. The stock had previously closed at C$0.28.
Nanalysis Scientific Price Performance
The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The company has a market capitalization of C$32.22 million, a price-to-earnings ratio of -2.38 and a beta of 0.72. The company has a 50-day moving average price of C$0.31 and a 200-day moving average price of C$0.34.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
See Also
- Five stocks we like better than Nanalysis Scientific
- What is the Hang Seng index?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Canada Bond Market Holiday: How to Invest and Trade
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Top Stocks Investing in 5G Technology
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
